
Oncolib is an oral targeted therapy, used to treat adults with HR-positive, HER2-negative advanced or metastatic breast cancer. It is prescribed to be taken in combination with other hormone therapies, such as an aromatase inhibitor or fulvestrant.
Take Oncolib exactly as prescribed by your doctor which is a 4-week cycle, where Oncolib is taken once daily for three weeks (21 days) and one week off. It is also important to take note of the following:
Most Common Side effects:
Serious side effects:
Before taking Oncolib you must tell your doctor about all of your previous or existing medications and medical conditions including if: